Eiconic Labs Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 07-07-2024
- Paid Up Capital ₹ 0.10 M
as on 07-07-2024
- Company Age 9 Year, 5 Months
- Last Filing with ROC 31 Mar 2022
- Revenue %
(FY 2022)
- Profit 51.74%
(FY 2022)
- Ebitda 95.87%
(FY 2022)
- Net Worth -48.20%
(FY 2022)
- Total Assets -1.10%
(FY 2022)
About Eiconic Labs
The Corporate was formerly known as Iconic Generics India Private Limited. The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Ganesh Jhabua, Jai Jhabua, Rahul Muchhal, and Two other members serve as directors at the Company.
- CIN/LLPIN
U33110MP2015PTC034462
- Company No.
034462
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Jul 2015
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Company Details
- Location
Indore, Madhya Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Eiconic Labs?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ganesh Jhabua  | Director | 17-Sep-2017 | Current |
| Jai Jhabua | Director | 17-Sep-2017 | Current |
| Rahul Muchhal | Director | Current | |
| Suresh Sigtia | Director | 17-Sep-2017 | Current |
| Karn Sigtia | Director | 16-Jul-2015 | Current |
Financial Performance of Eiconic Labs.
Eiconic Labs Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 51.74% increase in profit. The company's net worth observed a substantial decline by a decrease of 48.2%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Eiconic Labs?
In 2017, Eiconic Labs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Omshiva Formulation Private LimitedActive 11 years 2 monthsGanesh Jhabua, Jai Jhabua and 2 more are mutual person
- Iconic Bituminous Private LimitedActive 16 years 1 month
Ganesh Jhabua, Jai Jhabua and 2 more are mutual person
- Parijat Cinematic Enterprises Pvt LtdActive 51 years 8 months
Ganesh Jhabua and Jai Jhabua are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Eiconic Labs?
Unlock and access historical data on people associated with Eiconic Labs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Eiconic Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Eiconic Labs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
